We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+1.04%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$1.2B
AUM Growth
-$33.6M
Cap. Flow
+$15.8M
Cap. Flow %
1.32%
Top 10 Hldgs %
22.6%
Holding
147
New
20
Increased
35
Reduced
44
Closed
20

Top Buys

Rank Stock Value
1
EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
+$37.2M
2
NARI
Inari Medical, Inc. Common Stock
NARI
+$24.3M
3
HCAT icon
Health Catalyst
HCAT
+$24.1M
4
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$22.2M
5
CELL
PhenomeX Inc. Common Stock
CELL
+$16M

Top Sells

Rank Stock Value
1
TFX icon
Teleflex
TFX
+$21.8M
2
AXNX
Axonics, Inc. Common Stock
AXNX
+$21.4M
3
RGEN icon
Repligen
RGEN
+$20M
4
OSH
Oak Street Health, Inc.
OSH
+$18.8M
5
NEUE
NeueHealth
NEUE
+$15.7M

Sector Composition

Rank Sector Weight
1 Healthcare 94.67%
2 Industrials 4.36%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PROC
101
DELISTED
Procaps Group, S.A. Ordinary Shares
PROC
$2.8M 0.23%
+274,275
New +$2.8M
AMGN icon
102
Amgen
AMGN
$208B
$2.8M 0.23%
13,153
– –
SYK icon
103
Stryker
SYK
$125B
$2.43M 0.2%
9,200
-4,500
-33% -$1.2M
CI icon
104
Cigna
CI
$73.7B
$2.31M 0.19%
11,547
-12,350
-52% -$2.69M
REGN icon
105
Regeneron Pharmaceuticals
REGN
$78.5B
$2.25M 0.19%
3,720
-500
-12% -$310K
ONC
106
BeOne Medicines Ltd
ONC
$32.8B
$2.18M 0.18%
6,000
– –
CMPI
107
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
$2.15M 0.18%
541,766
– –
MASS icon
108
908 Devices
MASS
$329M
$2.09M 0.17%
+64,250
New +$2.18M
GILD icon
109
Gilead Sciences
GILD
$162B
$2.04M 0.17%
29,250
– –
CTSO icon
110
Cytosorbents Corp
CTSO
$22.7M
$1.99M 0.17%
244,660
– –
VRTX icon
111
Vertex Pharmaceuticals
VRTX
$121B
$1.76M 0.15%
9,721
– –
TBIO
112
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$1.71M 0.14%
8,539
-20,145
-70% -$5.11M
TNDM icon
113
Tandem Diabetes Care
TNDM
$1.34B
$1.64M 0.14%
13,750
-18,350
-57% -$2.02M
ILMN icon
114
Illumina
ILMN
$31B
$1.61M 0.13%
4,071
– –
BOLT icon
115
Bolt Biotherapeutics
BOLT
$7.67M
$1.47M 0.12%
5,796
-7,013
-55% -$1.98M
ZLAB icon
116
Zai Lab
ZLAB
$2.06B
$622K 0.05%
5,900
– –
INCY icon
117
Incyte
INCY
$24.2B
$565K 0.05%
8,210
– –
ARGX icon
118
argenx
ARGX
$53.4B
$474K 0.04%
1,570
-300
-16% -$95.1K
MRTX
119
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$451K 0.04%
2,551
+120
+5% +$19.3K
RDY icon
120
Dr. Reddy's Laboratories
RDY
$9.87B
$420K 0.03%
32,270
– –
LEGN icon
121
Legend Biotech
LEGN
$3.59B
$374K 0.03%
7,400
– –
CRSP icon
122
CRISPR Therapeutics
CRSP
$4.73B
$366K 0.03%
3,270
– –
LITS
123
Lite Strategy Inc
LITS
$32.8M
$356K 0.03%
6,449
– –
FUSN
124
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$303K 0.03%
+38,198
New +$322K
BNTX icon
125
BioNTech
BNTX
$22.9B
$300K 0.03%
+1,100
New +$350K
2 3 4
5
6

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q3 2021 Portfolio in Review

As of Q3 2021, Sectoral Asset Management held 147 positions worth $1.2B, down 2.7% from $1.24B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Sectoral Asset Management's Q3 2021 filing shows 20 new, 35 increased, 44 reduced and 20 closed positions. Its largest new stake was eFFECTOR Therapeutics, Inc. Common Stock: 115,310 shares worth $40.5M. The largest sale was Teleflex, an estimated $21.8M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 94% a quarter earlier, followed by Industrials and Financials.

  • Sectoral Asset Management's largest Q3 2021 buy was eFFECTOR Therapeutics, Inc. Common Stock: 115,310 shares worth $40.5M.
  • Sectoral Asset Management added most to Treace Medical Concepts in Q3 2021, an estimated $8.26M increase.
  • Sectoral Asset Management's biggest Q3 2021 reduction was Teleflex, cutting an estimated $21.8M.
  • Sectoral Asset Management fully exited Oak Street Health, Inc. in Q3 2021, selling an estimated $18.8M.
  • Sectoral Asset Management's ten largest holdings make up 23% of its $1.2B portfolio in Q3 2021.
  • Sectoral Asset Management opened 20 new positions and closed 20 in Q3 2021.
  • Sectoral Asset Management's portfolio value fell 2.7% quarter-over-quarter to $1.2B.

Based on Sectoral Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.